VeGen Labs secures ₹3.765 cr BIRAC funding for KRAS inhibitor development
Funding to support IND-enabling toxicology studies for non-small cell lung cancer treatment
Recover your password.
A password will be e-mailed to you.
- Advertisement -
- Advertisement -
Recover your password.
A password will be e-mailed to you.